A New Jersey federal court construed “crystalline Form A” in a risdiplam patent without importing every characteristic described in the specification.
An Eastern District of Texas judge let patent owners accuse a not-yet-released product before serving infringement contentions, but refused a temporary restraining order because their showing rested only on the defendants’ marketing statements, with no physical product or specifications to compare against the claims.
The PTAB held all challenged claims of Inari Medical’s hemostasis-valve patent obvious because known looped strings and wires predictably improved a prior-art catheter valve’s seal.
In a claim construction ruling on a coke oven corbel patent, the court gave “above” and “gas source” their plain meaning (with a clarification for “gas source”) and rejected an indefiniteness challenge to the “third passageway” limitation.
After a patent case pending since 2015, a Delaware federal judge held that claims directing bit and phase scrambling to reduce peak-to-average power ratio are patent-eligible, but that claims for calculating scrambled phases without applying them are abstract and lack an inventive concept.
The Federal Circuit held that Microsoft Word metadata can independently corroborate an inventor’s testimony and upheld Valtrus’s earlier conception and diligence showing.
A Massachusetts federal court construed four terms in Nike’s Flyknit patent case, including limits for footwear, flat-knit edges, heel structures, and ankle parts.
The UPC upheld Align Technology’s clear-aligner patent, found Angelalign’s Torque Ridge products literally infringed, and ordered coordinated relief across seventeen countries.
In construing claims across seven ballistic-blind patents, a Delaware federal court held that “blind” is not limited to slats and “anti-ballistic” is definite, but found the term “decorative” indefinite as too subjective.
The Federal Circuit affirmed the PTAB’s anticipation and obviousness rulings against UPL’s fungicide patent and upheld denial of Syngenta’s proposed sanctions motion.
Sitting by designation in Delaware, Federal Circuit Judge Bryson denied dismissal on patent eligibility grounds because the complaint plausibly alleged inventive concepts, but dismissed speculative pre-suit knowledge and multi-defendant direct infringement allegations with leave to amend.
A California federal court held all asserted claims in VirtaMove’s software-containerization patents invalid because three key terms lacked objective boundaries.
A California federal court allowed projector makers’ noninfringement and most invalidity theories to proceed but dismissed patent-misuse, antitrust, and unfair-practice claims with leave to amend.
An Eastern District of Texas judge invalidated one Cloud Byte patent because the company’s infringement theory placed every claimed element in the prior art, while allowing other claims to proceed.
An Eastern District of Texas judge refused to grant Anker summary judgment on multiple NEC patents, finding factual disputes over infringement and willfulness.
An Eastern District of Texas judge held that Oribel’s limited marking efforts could not support pre-suit patent damages, while leaving infringement and lost-profit issues for trial.
A Texas federal court held that NetLens received all substantial rights needed to sue Microsoft, but not the express right to recover for infringement predating its patent license.
The Federal Circuit affirmed the rejection of a mobile-messaging patent application because the applicant failed to preserve substantive challenges to the examiner’s and PTAB’s indefiniteness rulings.
A California federal court dismissed DirecTV’s challenge to ten Adeia patents because portfolio licensing demands and confidential negotiations did not create a sufficiently concrete patent-specific controversy.
The Federal Circuit broadened the ordinary meaning of “joined,” ordered partial summary judgment of infringement on three powered cover-plate patent claims, and affirmed noninfringement on others.
The Federal Circuit held that a live patent-case indemnification dispute was not moot and qualified for Rule 60(b)(1) relief, while directing dismissal without prejudice after the parties agreed federal supplemental jurisdiction should end.
The Federal Circuit held that later experimental data may show whether a patent enabled its full scope and affirmed the invalidation of an enormous enzyme genus.
A New Jersey federal court construed “defibrotide” to require less than 10% double-stranded DNA because the patent applicants clearly surrendered broader scope during prosecution.
The Federal Circuit held that a scientifically impossible claim can be definite yet invalid because the patent cannot enable its full scope.
The Federal Circuit dismissed ParkerVision’s appeal because unresolved claims from the same patent prevented a final, appealable judgment.
The Federal Circuit affirmed that inadequate written-description support broke priority and made the inventor’s earlier publication invalidating prior art.
The Federal Circuit held that new claims and repackaged arguments did not satisfy the rule for reopening prosecution after a new Board rejection.
The EPO Board of Appeal found an organic binder was an obvious alternative in a nanocrystalline-abrasive patent and remanded fourteen auxiliary requests.
The Federal Circuit affirmed that prior-art codewords qualified as claimed feature vectors, leaving all challenged speech-recognition patent claims unpatentable for obviousness.
An Eastern District of Texas court let induced-infringement claims over contactless credit-card technology proceed and declined to invalidate five patents under Section 101 at the pleading stage.
An Eastern District of Texas court found AlexSam’s patent suit exceptional from filing and awarded Cigna $1.76 million because the infringement theory conflicted with an agreed construction and binding Federal Circuit guidance.
The UPC upheld Honeywell’s telescopic-conveyor patent, found post-license infringement, and ordered a six-country injunction plus provisional damages.
The Federal Circuit vacated a catheter-patent obviousness rejection because the PTAB construed “flow barrier” more broadly than the specification allowed.
The Federal Circuit affirmed a $3.24 million patent-case fee and expense award based on objectively baseless and bad-faith litigation conduct.
An Eastern District of Texas court found AlexSam’s patent case exceptional and awarded all reasonable defense fees because its infringement theory contradicted the agreed construction and prior appellate guidance.
Patent demand letters were protected under Noerr-Pennington, and a non-owner lacked the patent rights needed to remain a declaratory-judgment defendant.
The Federal Circuit held that TexasLDPC received all substantial patent rights, its enforcement-only business model did not terminate the license, and Texas A&M was not a required party.
The Federal Circuit vacated NCS Multistage’s infringement, validity, and damages judgments after correcting the construction of “casing string” and holding an earlier commercial tool was prior art.
The Federal Circuit preserved NCS Multistage’s contributory-infringement win against TCO but vacated the no-invalidity judgment under the corrected construction of “casing string.”
The Federal Circuit affirmed noninfringement, holding that “universal” spinal-implant preambles limit two patent claims and that substantial evidence supported the jury on a third.
A divided Federal Circuit affirmed noninfringement after construing a “cooperating service provider” as one that agrees to supply non-blocking bandwidth.
The Federal Circuit held that an unauthorized email did not timely commence a patent-term-adjustment challenge and that last-day filing problems did not warrant equitable tolling.
The Federal Circuit upheld a Section 285 fee award because Viavi inadequately investigated its infringement theory and continued pursuing it after contrary evidence emerged.
The Federal Circuit affirmed noninfringement because Biofer’s patent requires maintaining a pH between 7.0 and 9.0 throughout the claimed sugar-oxidation step.
The Federal Circuit affirmed three groups of PTAB decisions invalidating Netlist computer-memory patent claims as obvious.
The Federal Circuit affirmed that patent claims covering one-drop vitamin D delivery to infants were obvious over prior methods.
The Federal Circuit affirmed a PTAB ruling that preserved claims 1–13 but invalidated claims 14–18 of SpaceTime3D’s 3D webpage-interface patent.
The Federal Circuit affirmed PTAB decisions invalidating all challenged claims of two SpaceTime3D graphical-interface patents as obvious.
The Federal Circuit upheld written-description support for three Cabometyx patents while dismissing as moot and vacating a ruling on a fourth patent claim.
The Federal Circuit affirmed Samsung’s complete defense win, including a no-infringement verdict and a ruling that Qualcomm-chip devices remained licensed.